LEGN · Legend Biotech Corp ADR
United States · RS rating 70 · As of 2026-11-03
| Price | 21.48 USD |
|---|---|
| 1-day change | +1.8% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 89 / 84 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 21 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +27.3% |
| Sales growth Q/Q | +12.5% |
| Distance from 52-week high | +40.8% |
| Market cap (USD) | $4.4B |